AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 2:39 PM, AkshayaAI's signal for BBIO is Avoid ↓; the stock is at $79.86 (-1.66% today); neutral (RSI 46); news sentiment is positive.
Data as of Aug 14 2026, 2:39 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $79.86 |
| Change today | -1.66% |
| RSI (14) | 46.12 |
| Relative volume | 0.94 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $15.6B |
| Forward P/E | 1,593.06 |
| 52-week high | -14.5% away |
| 52-week low | +70.6% above |
| Technical trend | — |
| News sentiment | Positive |
| Sector | — |
| Next earnings | 8/10/2026 4:30:00 PM |
As of Aug 14 2026, 2:39 PM, AkshayaAI assigns BBIO (BridgeBio Pharma Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
BBIO's RSI is neutral (RSI 46). A reading above 70 is typically considered overbought and below 30 oversold.
BBIO is trading about 15% below its 52-week high and 71% above its 52-week low as of Aug 14 2026, 2:39 PM.
BBIO's next earnings date is 8/10/2026 4:30:00 PM.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 2:39 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.